𝔖 Bobbio Scriptorium
✦   LIBER   ✦

524 POTENTIAL SURVIVAL BENEFIT OF THE 5-VARIABLE MODEL FOR END-STAGE LIVER DISEASE (5VMELD) FOR LIVER TRANSPLANT ALLOCATION

✍ Scribed by R.P. Myers; A.A.M. Shaheen; P. Faris; A.I. Aspinall; K.W. Burak

Book ID
117379669
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
66 KB
Volume
54
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Liver transplant recipient survival bene
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era
✍ Carl L. Berg; Robert M. Merion; Tempie H. Shearon; Kim M. Olthoff; Robert S. Bro πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 236 KB πŸ‘ 1 views

Receipt of a living donor liver transplant (LDLT) has been associated with improved survival compared with waiting for a deceased donor liver transplant (DDLT). However, the survival benefit of liver transplant has been questioned for candidates with Model for Endstage Liver Disease (MELD) scores <1

Model for end-stage liver disease except
Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system
✍ Claire Francoz; Jacques Belghiti; Denis Castaing; Olivier ChazouillΓ¨res; Jean-Ch πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 437 KB πŸ‘ 1 views

Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not signific

The pediatric end-stage liver disease (P
The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients
✍ Neal R. Barshes; Timothy C. Lee; Ian W. Udell; Christine A. O'Mahoney; Saul J. K πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 190 KB πŸ‘ 1 views

The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for pediatric liver transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing liver transplantation (LT), if it correlates with posttr